CONTINUED AGAIN: DEA Announces A Second Extension of its “Temporary Rule” Addressing Telemedicine Flexibilities After the End of the COVID-19 Pandemic Emergency
FDA Law
OCTOBER 8, 2023
Next, on May 9, 2023 DEA, jointly with the Substance Abuse and Mental Health Services Administration (SAMHSA), issued the First Temporary Rule , which extended the full set of telemedicine flexibilities regarding the prescribing of controlled medications through November 11, 2023. 69,879, 69,880 (Oct. 10, 2023) (emphasis added).
Let's personalize your content